Literature DB >> 2644575

A case of nephrotic syndrome with glomerular lipoprotein deposition with capillary ballooning and mesangiolysis.

Y Watanabe1, I Ozaki, F Yoshida, A Fukatsu, Y Itoh, S Matsuo, N Sakamoto.   

Abstract

A 33-year-old man with nephrotic syndrome and rapid deterioration of renal function showed curious glomerular morphological abnormalities. Ballooning of the glomerular capillaries due to a substance accumulated in the capillary lumina and mesangiolysis were prominent histological features. The deposits in the capillary lumen were positive for Sudan III staining, and also for beta-lipoprotein, apoprotein B and apoprotein E by immunofluorescent technique. The staining of beta-lipoprotein in a flower leaf pattern was a striking characteristic, while such staining was negative when studied in 20 patients with nephrotic syndrome who were used as controls. Based on these findings, the morphological abnormalities in this case were considered to be related to lipoprotein deposition in the glomeruli. This case is thought to be the first reported in a complete form in the literature which could be classified as a new kind of disease related to lipoprotein metabolism abnormalities.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2644575     DOI: 10.1159/000185297

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  12 in total

1.  Scavenger receptor expressions in the kidneys of mice with lipoprotein glomerulopathy.

Authors:  Yoshiro Miyahara; Shinsuke Nishimura; Maho Watanabe; Kenji Ito; Hitoshi Nakashima; Takao Saito
Journal:  Clin Exp Nephrol       Date:  2011-11-11       Impact factor: 2.801

2.  Long-term follow-up of a paediatric case of lipoprotein glomerulopathy.

Authors:  Y Koitabashi; M Ikoma; T Miyahira; R Fujita; H Mio; M Ishida; K Shimizu; H Sakaguchi
Journal:  Pediatr Nephrol       Date:  1990-03       Impact factor: 3.714

3.  Successful treatment of lipoprotein glomerulopathy in a daughter and a mother using niceritrol.

Authors:  Hiroko Hamatani; Keiju Hiromura; Keiko Kobatake; Hiroaki Yoshida; Satsuki Kobayashi; Naohiro Yoneda; Ken Kayakabe; Takayuki Matsumoto; Takashi Kuroiwa; Kazue Ueki; Yoshihisa Nojima
Journal:  Clin Exp Nephrol       Date:  2010-09-15       Impact factor: 2.801

4.  Improvement of nephrotic syndrome by intensive lipid-lowering therapy in a patient with lipoprotein glomerulopathy.

Authors:  Akira Matsunaga; Masayuki Furuyama; Taeko Hashimoto; Kentaro Toyoda; Daisuke Ogino; Kiyoshi Hayasaka
Journal:  Clin Exp Nephrol       Date:  2009-07-15       Impact factor: 2.801

Review 5.  Arterial hypertension and hyperlipidemia as determinants of glomerulosclerosis.

Authors:  H J Gröne; A K Walli; E F Gröne
Journal:  Clin Investig       Date:  1993-10

6.  Lipoprotein glomerulopathy induced by ApoE-Sendai is different from glomerular lesions in aged apoE-deficient mice.

Authors:  Atsunori Ishimura; Maho Watanabe; Hitoshi Nakashima; Kenji Ito; Katsuhisa Miyake; Shizue Mochizuki; Yasushi Ishigaki; Takao Saito
Journal:  Clin Exp Nephrol       Date:  2009-05-21       Impact factor: 2.801

Review 7.  Lipoprotein glomerulopathy-like disease in a patient with type III hyperlipoproteinemia due to apolipoprotein E2 (Arg158 Cys)/3 heterozygosity.

Authors:  Miho Karube; Kimimasa Nakabayashi; Yasunori Fujioka; Ken Yoshihara; Akira Yamada; Akira Matsunaga; Takao Saito
Journal:  Clin Exp Nephrol       Date:  2007-06-28       Impact factor: 2.801

Review 8.  Topics in lipoprotein glomerulopathy: an overview.

Authors:  Takao Saito; Akira Matsunaga; Kenji Ito; Hitoshi Nakashima
Journal:  Clin Exp Nephrol       Date:  2013-10-23       Impact factor: 2.801

9.  Identification of apolipoprotein E Guangzhou (arginine 150 proline), a new variant associated with lipoprotein glomerulopathy.

Authors:  Boxun Luo; Fengxian Huang; Qicai Liu; Xiaoyan Li; Wenfang Chen; Shu-Feng Zhou; Xueqing Yu
Journal:  Am J Nephrol       Date:  2007-11-29       Impact factor: 3.754

Review 10.  Disturbances of lipid metabolism in children with chronic renal failure.

Authors:  U Querfeld
Journal:  Pediatr Nephrol       Date:  1993-12       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.